Could the pandemic help boost diversity in clinical trials?

The pandemic has exposed troubling inequities in the United States that have left Black and Hispanic people at higher risk of dying from COVID-19—and getting a smaller share of vaccines.

You may also like...

Leave a Reply

Your email address will not be published. Required fields are marked *

The information on this site is of a general nature only and is not intended to address the specific circumstances of any particular individual or entity. It is not intended or implied to be a substitute for professional advice. Read more.